Company News
Ipsen to Acquire Memo Therapeutics for €700M
Ipsen agreed to acquire Swiss biotech Memo Therapeutics for over €700 million (~$800 million).
The deal includes €200 million upfront with further payments tied to development, regulatory and sales mi
